Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

L-type Ca2+ channels in Ca2+ channelopathies.

Jörg Striessnig1, Jean-Charles Hoda, Alexandra Koschak

  • 1Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, Peter-Mayr-Strasse 1, A-6020 Innsbruck, Austria. joerg.striessnig@uibk.ac.at

Biochemical and Biophysical Research Communications
|September 1, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain voltage-gated Ca2+ channels and calmodulin: Teaming up in calmodulinopathies?

The Journal of general physiology·2026
Same author

Ownership changes in the pharmaceutical industry: understanding the 2023 pharma mergers and acquisitions landscape of Europe.

Journal of pharmaceutical policy and practice·2026
Same author

Public contributions to the development of antibiotics: two successful and two failed investments.

Journal of pharmaceutical policy and practice·2026
Same author

Make or break - PEDS1 and AGMO orchestrate ether lipid homeostasis in human adipocytes and are associated with blood lipid profiles.

Journal of translational medicine·2026
Same author

Characterization of Tiroler Bergkäse PDO cheese: A multimethodological approach.

Food chemistry. Molecular sciences·2026
Same author

Aberrant calcium signaling and neuronal activity in the L271H CACNA1D (Cav1.3) iPSC model of neurodevelopmental disease.

Molecular psychiatry·2026

Voltage-gated L-type Ca2+ channels (LTCCs) are crucial for cell function. This review explores how LTCC gene defects cause human diseases, including neurological disorders, highlighting their role in channelopathies.

Area of Science:

  • Molecular biology
  • Human physiology
  • Neuroscience

Background:

  • Voltage-gated L-type Ca2+ channels (LTCCs) facilitate calcium ion (Ca2+) influx into excitable cells.
  • LTCCs are vital for muscle contraction, neuronal signaling, and endocrine/sensory cell function.

Purpose of the Study:

  • To review the role of LTCCs in human diseases stemming from genetic Ca2+ channel defects (channelopathies).
  • To examine how LTCC dysfunction contributes to various channelopathies and associated symptoms.

Main Methods:

  • Literature review of studies on LTCCs and human genetic diseases.
  • Analysis of genetic mutations affecting LTCC alpha1 subunits.
  • Examination of mouse models with Ca2+ channelopathies.

Related Experiment Videos

Main Results:

  • LTCC dysfunction due to structural defects in alpha1 subunits is linked to conditions like congenital stationary night blindness, malignant hyperthermia, and hypokalemic periodic paralysis.
  • LTCCs are implicated in neurological symptoms of channelopathies affecting other Ca2+ channels, as seen in tottering mice (Ca(v)2.1 alpha1 dysfunction).

Conclusions:

  • Genetic defects in LTCCs are a direct cause of specific human channelopathies.
  • LTCCs play a significant, though sometimes indirect, role in the pathophysiology of neurological channelopathies.
  • Studying Ca2+ channelopathies offers insights into the diverse functions of LTCC isoforms in human health and disease.